India’s first Covid-19 vaccine candidate by Hyderabad-based Bharat Biotech set for trials

India’s first Covid-19 vaccine candidate Covaxin, developed by Hyderabad-based Bharat Biotech in collaboration with the National Institute of Virology (NIV), has received Drug Controller General of India (DCGI) approval for phase I and II human trials.